Möchten Sie immer auf dem neuesten Stand bleiben?

Ongoing Phase 1 trial of CTIM-76 (CLDN6 x CD3) demonstrates encouraging antitumor activity and safety Ongoing Phase 1 trial of CT-95 (MSLN x CD3) is approaching target dose levels Cash and cash...

RADNOR, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and...

RESTON, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results...

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...

PANAMA CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The clock is ticking as the Blazpay crypto presale races toward one of its biggest turning points yet. With less than 24 hours remaining before Phase 3...

Check Point secured highest score in NSS Labs’ Enterprise Firewall Test with a 99.59% security effectiveness rating, reaffirming its leadership.

Austin, TX, USA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Precision Swine Farming Market Size, Trends and Insights By System Type (Swine...

Ottawa, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The cement packaging market size surpassed USD 4.85 billion in 2024 and is estimated to hit around USD 6.87 billion by 2034, growing at a CAGR of 3.55% from...

New York, USA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Choroidal Neovascularization Market to Witness Accelerated Growth Throughout the Forecast Period (2025–2034) Due to Advancement in Anti-VEGF...